Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HERC5/IFI16/p53 signaling mediates breast cancer cell proliferation and migration. | Life Sci | 2022 | 35671810 | PubTator, text mining | PubMed |
| THO complex deficiency impairs DNA double-strand break repair via the RNA surveillance kinase SMG-1. | Nucleic Acids Res | 2022 | 35670662 | PubTator, text mining | PubMed |
| Complete response to pembrolizumab in a patient with dermatomyositis and MMR deficient ovarian cancer: A case report. | Gynecol Oncol Rep | 2022 | 35663849 | PubTator, text mining | PubMed |
| Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests. | Oncogene | 2022 | 35662281 | PubTator, text mining | PubMed |
| The "Inside" Story on Tumor-Expressed PD-L1. | Cancer Res | 2022 | 35661198 | PubTator, text mining | PubMed |
| Comprehensive evaluation and efficient classification of BRCA1 RING domain missense substitutions. | Am J Hum Genet | 2022 | 35659930 | PubTator, text mining | PubMed |
| PPM1D in Solid and Hematologic Malignancies: Friend and Foe? | Mol Cancer Res | 2022 | 35657598 | PubTator, text mining | PubMed |
| Somatic non-cancerous overgrowth syndrome of obscure molecular etiology: what are the causes and options? | J Mol Med (Berl) | 2022 | 35657398 | PubTator, text mining | PubMed |
| Germline genetics of prostate cancer. | Prostate | 2022 | 35657157 | PubTator, text mining | PubMed |
| Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic Mutations. | Cancer Epidemiol Biomarkers Prev | 2022 | 35654374 | PubTator, text mining | PubMed |
| BARD1 mystery: tumor suppressors are cancer susceptibility genes. | BMC Cancer | 2022 | 35650591 | PubTator, text mining | PubMed |
| Applications of Proteomics in Ovarian Cancer: Dawn of a New Era. | Proteomes | 2022 | 35645374 | PubTator, text mining | PubMed |
| Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort. | BMC Cancer | 2022 | 35643464 | PubTator, text mining | PubMed |
| A Motif-Based Network Analysis of Regulatory Patterns in Doxorubicin Effects on Treating Breast Cancer, a Systems Biology Study. | Avicenna J Med Biotechnol | 2022 | 35633986 | PubTator, text mining | PubMed |
| The Existence of at Least Three Genomic Signature Patterns and at Least Seven Subtypes of COVID-19 and the End of the Disease. | Vaccines (Basel) | 2022 | 35632517 | PubTator, text mining | PubMed |
| Integrated Deadenylase Genetic Association Network and Transcriptome Analysis in Thoracic Carcinomas. | Molecules | 2022 | 35630580 | PubTator, text mining | PubMed |
| Double-Stranded Break Repair in Mammalian Cells and Precise Genome Editing. | Genes (Basel) | 2022 | 35627122 | PubTator, text mining | PubMed |
| Homologous Recombination Repair in Biliary Tract Cancers: A Prime Target for PARP Inhibition? | Cancers (Basel) | 2022 | 35626165 | PubTator, text mining | PubMed |
| Prognostic Neurotransmitter Receptors Genes Are Associated with Immune Response, Inflammation and Cancer Hallmarks in Brain Tumors. | Cancers (Basel) | 2022 | 35626148 | PubTator, text mining | PubMed |
| Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. | Cancers (Basel) | 2022 | 35626089 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=54